-
公开(公告)号:US11690820B2
公开(公告)日:2023-07-04
申请号:US17457126
申请日:2021-12-01
发明人: Ian Osterloh , Pierre Wicker , Rene Braeckman , Paresh Soni , Mehar Manku
IPC分类号: A61K31/202 , A61K45/06 , A61K31/222 , A61K31/232 , A61K31/40 , A61K31/505 , A61K9/48 , A61K47/22 , A61K47/26 , A61K47/34 , A61K31/74 , A61P3/06
CPC分类号: A61K31/202 , A61K9/48 , A61K31/222 , A61K31/232 , A61K31/40 , A61K31/505 , A61K45/06 , A61K47/22 , A61K47/26 , A61K47/34 , A61K31/74 , A61P3/06 , A61K31/202 , A61K2300/00
摘要: The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
-
公开(公告)号:US11672832B2
公开(公告)日:2023-06-13
申请号:US16467154
申请日:2017-12-08
发明人: Jianping Fu , Deborah Gumucio , Yue Shao , Kenichiro Taniguchi , Yi Zheng , Sajedeh Nasr Esfahani
CPC分类号: A61K35/545 , A61K31/74 , A61K35/50 , C12N5/0068 , C12N5/0605 , G01N33/5044 , C12N2502/45 , C12N2533/30
摘要: The present disclosure provides compositions and methods employing stem cell-derived amnion tissue. In some embodiments, compositions (e.g., scaffolds and devices) and methods of generating amnion-like tissues from hPSCs are provided. In some embodiments, uses of such cells for research, compound screening and analysis, and therapeutics are provided.
-
公开(公告)号:US20230085710A1
公开(公告)日:2023-03-23
申请号:US17988625
申请日:2022-11-16
IPC分类号: A61K31/713 , A61K47/50 , A61K9/00 , A61K9/08 , C07K16/28 , A61K47/26 , A61K31/15 , A61K47/69 , A61K31/74 , A61K9/19
摘要: The present invention relates to compositions comprising polyinosinic (poly(I))-polycytidylic acid poly(C) molecules, or a salt and/or solvate thereof, comprising double-stranded polyribonucleotides. The present invention further relates to compositions wherein the disclosed respective poly(I) and poly(C) single-stranded molecules are annealed to thereby form double-stranded poly(I:C) molecules.
-
公开(公告)号:US11484591B2
公开(公告)日:2022-11-01
申请号:US16078860
申请日:2017-02-22
IPC分类号: A61K39/395 , A61K31/565 , A61K31/167 , A61K45/00 , A61K47/10 , A61K31/74 , C07K16/28 , A61P35/00 , A61K39/00
摘要: The present disclosure is directed to formulations and methods for treatment of disease such as chemoprevention of cancer, for example oral squamous cell carcinoma (OSCC), and for methods of preparing the formulations. Further, the disclosure relates to local administration in slow release dosage forms for treatment of disease. The extended-release formulations are comprised of biodegradable polymeric implants (for example millicylinders and microspheres as well as in situ forming gels) and therapeutic agents selected from an anti-interleukin 6 agent, a synthetic vitamin A analogue and/or metabolite, and/or an estradiol metabolite for the local delivery of therapeutic agents to a site where a cancer has been previously excised or to prevent progression of a precancerous lesion.
-
公开(公告)号:US11369578B2
公开(公告)日:2022-06-28
申请号:US17013024
申请日:2020-09-04
发明人: Susan Ciotti
IPC分类号: A61K31/74 , A61K31/14 , A61K47/44 , A61K9/00 , A61K9/107 , A61K31/34 , A61K31/427 , A61K31/4706 , A61K31/513 , A61K31/53 , A61K31/685 , A61K31/7064 , A61K38/21 , A61K45/06 , A61K47/26 , A61K47/34 , A61P31/14
摘要: The present disclosure relates to nanoemulsion compositions with certain surfactant blend ratios that impart enhanced permeability. Such compositions are useful for topical, mucosal and intranasal applications and allow for the greater delivery of one or more active agents to the application site to prevent infection by a microorganism.
-
公开(公告)号:US20220125828A1
公开(公告)日:2022-04-28
申请号:US17557108
申请日:2021-12-21
发明人: Ali Fathi , Fariba Dehghani
IPC分类号: A61K31/74 , A61K47/58 , A61K47/59 , A61K47/61 , A61K47/69 , A61K47/60 , A61K31/78 , A61L27/16 , A61L27/52 , A61L27/54 , A61L27/58
摘要: According to the present invention there is provided a polymer comprising at least one antiseptic/analgesic/anti-inflammatory monomeric unit in conjunction with at least three further monomeric units, said three further monomeric units eliciting properties selected from the group consisting of temperature activation, water solubility, mechanical strength, protein/polysaccharide bonding capacity, and combinations thereof. In particular, disclosed herein is a polymer, wherein the water-soluble monomeric unit is a hydrophilic ethylene glycol (OEGMA) moiety: the mechanical strength-conferring monomeric unit is polylactide-co-2-hydroxy-ethyl-methyl acrylate (PLA/HEMA); the protein-reactive monomeric unit is an N-acryloxysuccinimide (NAS) moiety; and the thermosetting monomeric unit is an N-isopropyl acrylamide (NIPAAm) moiety. The anti-septic/analgesic/anti-inflammatory monomeric unit comprises a methacrylic ester derivative of salicylic acid (5-HMA or 4-HMA, or a combination thereof).
-
公开(公告)号:US20210402015A1
公开(公告)日:2021-12-30
申请号:US17409578
申请日:2021-08-23
申请人: Kodiak Sciences Inc.
发明人: Stephen A. CHARLES , Daniel Victor PERLROTH , Didier G. BENOIT , Lane A. CLIZBE , Wayne TO , Linda J. ZADIK , Jeanne M. PRATT
IPC分类号: A61K51/06 , C08F230/02 , A61K47/58 , A61K31/74 , A61K47/68 , C08F2/50 , C08F2/06 , C08F20/26 , C08F2/04 , C08F20/18 , A61K49/00
摘要: The present invention provides multi-armed high MW polymers containing hydrophilic groups and one or more functional agents, and methods of preparing such polymers.
-
公开(公告)号:US11007215B2
公开(公告)日:2021-05-18
申请号:US16721760
申请日:2019-12-19
申请人: OUROTECH, INC.
IPC分类号: C08J3/075 , A61K31/74 , A61L27/20 , A61L27/52 , A61L31/04 , C08J3/24 , C08K5/1545 , C08L5/04 , C08L5/08 , C08K5/00 , A61K9/00 , A61K31/724 , A61K38/02 , A61K47/22 , A61K47/26
摘要: A shear-thinning hydrogel composition includes: a first polymer chain including: (i) a first plurality of units each having at least one of a monosaccharide and an amino acid; and (ii) a cross-linking group bound to the at least one of the monosaccharide and the amino acid of one of the first plurality of units via conversion of a carboxyl group of the unit to a peptide bond; a second polymer chain including a second plurality of the units; and a cross-linking additive connecting one of the second plurality of units to the first polymer chain via the cross-linking group.
-
公开(公告)号:US10967001B2
公开(公告)日:2021-04-06
申请号:US16018603
申请日:2018-06-26
IPC分类号: A61K31/745 , A61K31/74 , A61K31/75 , A61K9/00 , A61K9/16 , A61K9/50 , B01J20/26 , B01J20/28 , B01J20/30 , C08F212/36 , C08J9/26 , A61K47/58
摘要: The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.
-
公开(公告)号:US20210038634A1
公开(公告)日:2021-02-11
申请号:US16980063
申请日:2019-03-12
发明人: Kazunori KATAOKA , Shigehito OSAWA , Satoshi UCHIDA , Kotaro HAYASHI , Anjaneyulu DIRISALA , Kazuko TOH
摘要: The present invention provides a composition that controls pharmacokinetics. Specifically, the present invention provides: a composition for controlling pharmacokinetics, the composition containing a polyvalent cation as an active ingredient; and a method for controlling pharmacokinetics using the polyvalent cation.
-
-
-
-
-
-
-
-
-